Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: A randomized, double-blind, placebo-controlled phase II dose-ranging study

Kim A. Papp, R. G. Langley, B. Sigurgeirsson, M. Abe, D. R. Baker, P. Konno, S. Haemmerle, H. J. Thurston, C. Papavassilis, H. B. Richards

Research output: Contribution to journal › Article › peer-review

327 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: A randomized, double-blind, placebo-controlled phase II dose-ranging study'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases

Immunology and Microbiology

Medicine and Dentistry